Skip to main content
. 2013 Jun 6;4(6):e654. doi: 10.1038/cddis.2013.186

Table 1. Expressional profiles of B4GALT gene family and P-gp, MRP1 in AML and CML patients with MDR.

Cases AML no. (%) CML no. (%)
Age
 <60 26 (89.7) 16 (43.2)
 ≥60 3 (10.3) 21 (56.8)
Gender
 Male 17 (58.6) 23 (62.2)
 Female 12 (41.4) 14 (37.8)
≥Twofold higher levels versus patients without MDR
 B4GALT1 19 (65.5)* 25 (67.6)*
 B4GALT2 2 (6.9) 3 (8.1)
 B4GALT3 0 (0) 4 (10.8)
 B4GALT4 0 (0) 0 (0)
 B4GALT5 16 (55.2)* 22 (59.5)*
 B4GALT6 0 (0) 0 (0)
 B4GALT7 0 (0) 0 (0)

Abbreviations: AML, acute myeloid leukemia; CML, chronic myeloid leukemia; MDR, multidrug resistance

*P<0.05 versus patients without MDR